Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06144385
Status:
RECRUITING
Last Update Posted:
2024-01-02
First Post:
2023-11-15
Brief Title:
A Phase 1 Single-arm Open-label Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Sponsor:
Shanghai Ming Ju Biotechnology Co Ltd
Organization:
Shanghai Ming Ju Biotechnology Co Ltd
Organization Data
Organization:
Shanghai Ming Ju Biotechnology Co Ltd
Class:
INDUSTRY
Study ID:
JWATM204001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Ming Ju Biotechnology Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None